Moti L. Kashyap,Shobha V. Kamanna,Vaijinath S. Kamanna
申请号:
US13988972
公开号:
US20130303548A1
申请日:
2011.11.22
申请国别(地区):
US
年份:
2013
代理人:
摘要:
Niacin prevents and/or reverses the development of experimental hepatic steatosis, deposition of triglycerides in liver and serum of individuals, deposition of total cholesterol in liver and serum in individuals, and inhibit liver lipid peroxidation and oxidative stress in individuals at risk of developing fatty liver disease or NAFLD. In cultured human hepatocytes, niacin inhibits alcohol-induced fat accumulation.